Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy

Mona Fani1,2, Maryam Moossavi3, Hasan Bakhshi1

  • 1Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Future Virology
|September 13, 2023
PubMed

Insights

Calcium channel blockers (CCBs) show promise for treating COVID-19 by inhibiting calcium channels essential for SARS-CoV-2 replication and inflammation. Targeting viroporins alongside CCBs may further limit viral spread.

Area of Science:

  • Virology
  • Pharmacology
  • Immunology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involves complex host-pathogen interactions.
  • Calcium ions (Ca2+) play a critical role in viral entry and inflammatory responses during SARS-CoV-2 infection.
  • Viroporins are viral proteins crucial for replication and pathogenesis, making them potential therapeutic targets.

Purpose of the Study:

  • To explore the potential of calcium channel blockers (CCBs) as a therapeutic strategy against SARS-CoV-2.
  • To investigate the dual role of calcium channels in viral fusion and inflammatory pathways.
  • To assess the combined therapeutic potential of CCBs and viroporin inhibitors for COVID-19 treatment.

Main Methods:

  • Review of existing evidence on calcium channel function in SARS-CoV-2.
  • Analysis of the role of Ca2+ in viral replication and host inflammatory responses.
  • Evaluation of viroporins as antiviral targets.

Main Results:

  • Ca2+ influx is necessary for the fusion process of SARS-CoV-2.
  • Inflammatory factors associated with SARS-CoV-2 infection are modulated by Ca2+ levels.
  • Inhibition of host calcium channels and viral viroporins can impede viral spread.

Conclusions:

  • Calcium channel blockers (CCBs) represent a viable therapeutic option for COVID-19.
  • Targeting both host calcium channels and viral viroporins offers a promising dual approach to antiviral therapy.
  • Further research into CCBs and viroporin inhibitors is warranted for effective SARS-CoV-2 management.

Related Concept Videos

Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...